241 — Alibaba Health Information Technology Share Price
Last trade - 00:00- HK$70.33bn
- HK$59.91bn
- CNY27.03bn
- 89
- 14
- 64
- 59
Growth & Value
| 12m Forecast Rolling | Industry | Market | |
|---|---|---|---|
| PE Ratio (f) | 29.19 | ||
| PEG Ratio (f) | 0.86 | ||
| EPS Growth (f) | 51.58% | ||
| Dividend Yield (f) | n/a | ||
| Valuation (ttm) | Industry | Market | |
|---|---|---|---|
| Price to Book Value | 4.41 | ||
| Price to Tang. Book | 4.77 | ||
| Price to Free Cashflow | 60.62 | ||
| Price to Sales | 2.37 | ||
| EV to EBITDA | 64.58 | ||
Shareholder Activity
| Type | Buy / Hold / Sell |
|---|---|
| Institutions | |
| Directors | |
| Community |
Guru Screens
Quality
| Name | Industry | Market | |
|---|---|---|---|
| Return on Capital | 6.48% | ||
| Return on Equity | 5.95% | ||
| Operating Margin | 3.52% | ||
Financial Summary
| Year End 31st Mar | Unit | 2020 | 2021 | 2022 | 2023 | 2024 | 2025E | 2026E | CAGR / Avg |
|---|---|---|---|---|---|---|---|---|---|
| Total Revenue | CNYm | 9,596.48 | 15,518.47 | 20,577.62 | 26,763.02 | 27,026.56 | 30,723.65 | 34,516.14 | 39.61% |
| Operating Profit | m | ||||||||
| Net Profit | m | ||||||||
| EPS Reported | |||||||||
| Diluted Normalised EPS | |||||||||
| EPS Growth | % | n/a | n/a | n/a | n/a | +65.43 | +102.47 | +29.66 | n/a |
| PE Ratio | x | ||||||||
| PEG | |||||||||
| Profitability | |||||||||
| Operating Margin | % | ||||||||
| ROA | % | ||||||||
| ROCE | % | ||||||||
| ROE | % | ||||||||
| Cashflow | |||||||||
| Op. Cashflow ps | |||||||||
| Capex ps | |||||||||
| Free Cashflow ps | |||||||||
| Dividends | |||||||||
| Dividend ps | |||||||||
| Dividend Growth | % | ||||||||
| Dividend Yield | % | ||||||||
| Dividend Cover | x | ||||||||
| Balance Sheet | |||||||||
| Cash etc | m | ||||||||
| Working Capital | m | ||||||||
| NFA | m | ||||||||
| Net Debt | m | ||||||||
| Book Value | m | ||||||||
| Diluted Weighted Average Shares | m | ||||||||
| Book Value ps | |||||||||
Other Ratios
| Leverage (ttm) | Total | - Intang | + Pension |
|---|---|---|---|
| Gross Gearing | |||
| Net Gearing | |||
| Cash / Assets |
| Liquidity (ttm) | |
|---|---|
| Curr. Ratio | |
| Quick Ratio | |
| Interest Cov. | |
| Efficiency (ttm) | |
|---|---|
| Asset Turnover | |
| Recs Turnover | |
| Stock Turnover | |
Recent History
| Latest interim period vs. prior period | Industry | Market | |
|---|---|---|---|
| Sales Growth | |||
| EPS Growth | |||
| 3yr Compound Annual Growth Rate | Industry | Market | |
|---|---|---|---|
| Sales CAGR | |||
| EPS CAGR | |||
| DPS CAGR | |||
Profile Summary
Alibaba Health Information Technology Ltd is an investment holding company mainly engaged in the provision of Internet solutions for the medical and pharmaceutical industry, and is Alibaba Group’s healthcare flagship platform. The Company is mainly involved in the development of pharmaceutical and healthcare product and service sales business, the operation of pharmaceutical e-commerce platform and consumer healthcare services platform, the development of tracking and digital health business and Internet healthcare business using technologies such as cloud computing and big data.
Directors
- Shunyan Zhu CHM (50)
- Difan Shen EDR (43)
- Yanwu Tu EDR (43)
- Wai Yan Lee SEC
- Faguang Li NED (45)
- Yi Fei Huang NID (48)
- Tong Luo NID (54)
- On King Wong NID (68)
- Last Annual
- March 31st, 2024
- Last Interim
- March 31st, 2024
- Incorporated
- March 11th, 1998
- Public Since
- July 6th, 1972
- No. of Employees
- 1,435
- Sector
- Food & Drug Retailing
- Industry
- Consumer Defensives
- Exchange
- Stock Exchange of Hong Kong Limited
- Shares in Issue
- 16,057,235,264
- Address
- 26/F,
- Web
- https://www.alihealth.cn/
- Phone
- +852 null25839333
- Auditors
- Ernst & Young CPA
Upcoming Events for 241
Similar to 241
Alpha Professional Holdings
Stock Exchange of Hong Kong Limited
Asia Grocery Distribution
Stock Exchange of Hong Kong Limited
Best Mart 360 Holdings
Stock Exchange of Hong Kong Limited
Beijing Properties (Holdings)
Stock Exchange of Hong Kong Limited
B & S International Holdings
Stock Exchange of Hong Kong Limited
FAQ
As of Today at 19:11 UTC, shares in Alibaba Health Information Technology are trading at HK$4.38. This share price information is delayed by 15 minutes.
Shares in Alibaba Health Information Technology last closed at HK$4.38 and the price had moved by -12.05% over the past 365 days. In terms of relative price strength the Alibaba Health Information Technology share price has underperformed the FTSE Developed Asia Pacific Index by -21.97% over the past year.
The overall consensus recommendation for Alibaba Health Information Technology is Buy. You can view the full broker recommendation list by unlocking its StockReport.
Find out moreAlibaba Health Information Technology does not currently pay a dividend.
Alibaba Health Information Technology does not currently pay a dividend.
Alibaba Health Information Technology does not currently pay a dividend.
To buy shares in Alibaba Health Information Technology you'll need a share-dealing account with an online or offline stock broker. Once you have opened your account and transferred funds into it, you'll be able to search and select shares to buy and sell. You can use Stockopedia’s share research software to help you find the the kinds of shares that suit your investment strategy and objectives.
As of the previous close price of HK$4.38, shares in Alibaba Health Information Technology had a market capitalisation of HK$70.33bn.
Here are the trading details for Alibaba Health Information Technology:
- Country of listing: Hong Kong
- Exchange: HKG
- Ticker Symbol: 241
Based on an overall assessment of its quality, value and momentum Alibaba Health Information Technology is currently classified as a High Flyer. The classification is based on a composite score that examines a wide range of fundamental and technical measures. Stock are classified on the the following spectrum: Super Stocks, High Flyers, Contrarians, Turnarounds, Neutral, Value Traps, Momentum Traps, Falling Stars, and Sucker Stocks. For more information, learn about our StockRank Styles.
The analyst consensus target price for shares in Alibaba Health Information Technology is HK$5.21. That is 19.03% above the last closing price of HK$4.38.
Analysts covering Alibaba Health Information Technology currently have a consensus Earnings Per Share (EPS) forecast of CNY0.12 for the next financial year.
Find out moreAn important predictor of whether a stock price will go up is its track record of momentum. Price trends tend to persist, so it's worth looking at them when it comes to a share like Alibaba Health Information Technology. Over the past six months, its share price has outperformed the FTSE Developed Asia Pacific Index by +49.24%.
As of the last closing price of HK$4.38, shares in Alibaba Health Information Technology were trading +31.11% higher than their 200 day moving average. You can read more about the power of momentum in assessing share price movements on Stockopedia.
The Alibaba Health Information Technology PE ratio based on its reported earnings over the past 12 months is 29.19. The shares last closed at HK$4.38.
The PE ratio (or price-to-earnings ratio) is the one of the most popular valuation measures used by stock market investors. It is calculated by dividing a company's price per share by its earnings per share.
The PE ratio can be seen as being expressed in years, in the sense that it shows the number of years of earnings which would be required to pay back the purchase price, ignoring inflation. So in general terms, the higher the PE, the more expensive the stock is.
Alibaba Health Information Technology's management team is headed by:
- Shunyan Zhu - CHM
- Difan Shen - EDR
- Yanwu Tu - EDR
- Wai Yan Lee - SEC
- Faguang Li - NED
- Yi Fei Huang - NID
- Tong Luo - NID
- On King Wong - NID